We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$123M
AUM Growth
+$5.54M
(+4.7%)
Cap. Flow
-$158K
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
35.93%
Holding
93
New
32
Increased
10
Reduced
17
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYCC
ClubCorp Holdings, Inc.
MYCC
|
+$4.82M |
| 2 |
AbbVie
ABBV
|
+$3.75M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.28M |
| 4 |
SHPG
Shire pic
SHPG
|
+$2.96M |
| 5 |
TripAdvisor
TRIP
|
+$2.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$3.61M |
| 2 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$3.47M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$2.83M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$2.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.6% |
| 2 | Communication Services | 11.98% |
| 3 | Industrials | 8.33% |
| 4 | Consumer Discretionary | 7.51% |
| 5 | Materials | 7.11% |
Similar funds
AGA
ATS
RIM
ACM
CAM
LSA
GWA
Atika Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Atika Capital Management held 93 positions worth $123M, up 4.7% from $117M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Atika Capital Management's Q2 2014 filing shows 32 new, 10 increased, 17 reduced and 31 closed positions. Its largest new stake was ClubCorp Holdings, Inc.: 262,000 shares worth $4.86M. The largest sale was Incyte, an estimated $3.61M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Communication Services and Industrials.
- Atika Capital Management's largest Q2 2014 buy was ClubCorp Holdings, Inc.: 262,000 shares worth $4.86M.
- Atika Capital Management added most to INTERMUNE INC in Q2 2014, an estimated $2.17M increase.
- Atika Capital Management's biggest Q2 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $3M.
- Atika Capital Management fully exited Incyte in Q2 2014, selling an estimated $3.61M.
- Atika Capital Management's ten largest holdings make up 36% of its $123M portfolio in Q2 2014.
- Atika Capital Management opened 32 new positions and closed 31 in Q2 2014.
- Atika Capital Management's portfolio value rose 4.7% quarter-over-quarter to $123M.
Based on Atika Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.